Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients.
暂无分享,去创建一个
M. de Lorgeril | J. Ninet | J. Martín | S. Renaud | P. Boissonnat | N. Mamelle | G. Dureau | J. Guidollet | I. Monjaud
[1] M. de Lorgeril,et al. Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients. , 1993, Transplantation.
[2] D. Mikhailidis,et al. Accelerated coronary artery disease after heart transplantation: the role of enhanced platelet aggregation and thrombosis , 1993, Journal of internal medicine.
[3] J. Arnaud,et al. Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis. , 1993, American heart journal.
[4] B. Hunt,et al. HEMOSTATIC CHANGES IN HEART TRANSPLANT RECIPIENTS AND THEIR RELATIONSHIP TO ACCELERATED CORONARY SCLEROSIS , 1993, Transplantation.
[5] S. Kushwaha,et al. Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients , 1992, The Lancet.
[6] G. T. Jones. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men , 1992 .
[7] M. de Lorgeril,et al. Platelet function and composition in heart transplant recipients compared with nontransplanted coronary patients. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[8] J. Emond,et al. HEPATIC ARTERY THROMBOSIS IN INFANTS A COMPARISON OF WHOLE LIVERS, REDUCED‐SIZE GRAFTS, AND GRAFTS FROM LIVING‐RELATED DONORS 1 , 1992, Transplantation.
[9] M. de Lorgeril,et al. Increased lipid peroxidation in cyclosporin-treated heart transplant recipients. , 1991, The American journal of cardiology.
[10] A. Bluhm. Ischemic heart disease and platelet aggregation: The caerphilly collaborative heart disease study , 1991 .
[11] M. Ovize,et al. Increased platelet aggregation after heart transplantation: influence of aspirin. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] R. Wilson,et al. Evidence for Structural Sympathetic Reinnervation After Orthotopic Cardiac Transplantation in Humans , 1991, Circulation.
[13] S. Alexander,et al. Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study. , 1991, Transplantation.
[14] S. Hunt,et al. Progressive coronary luminal narrowing after cardiac transplantation. , 1990, Circulation.
[15] M. Yacoub,et al. Coronary artery spasm after cardiac transplantation. , 1990, The American journal of cardiology.
[16] R. Collins,et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. , 1989, Circulation.
[17] J. Schroeder,et al. The spectrum of coronary artery pathologic findings in human cardiac allografts. , 1989, The Journal of heart transplantation.
[18] L. Simons,et al. Platelet activation by oxidatively modified low density lipoproteins. , 1989, Atherosclerosis.
[19] C Kawai,et al. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I. , 1988, The Journal of clinical investigation.
[20] A. Grace,et al. Cyclosporine A enhances platelet aggregation. , 1987, Kidney international.
[21] M E Billingham,et al. Cardiac transplant atherosclerosis. , 1987, Transplantation proceedings.
[22] T. Lerut,et al. THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS , 1985, The Lancet.
[23] A. Buda,et al. Coronary artery spasm in the denervated transplanted human heart: a clue to underlying mechanisms. , 1981, The American journal of medicine.
[24] E. Michelson,et al. Instantaneous and Delayed Ventricular Arrhythmias After Reperfusion of Acutely Ischemic Myocardium: Evidence for Multiple Mechanisms , 1981, Circulation.
[25] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[26] M. Yacoub,et al. Detection of Anti-Endothelial Antibodies by Western Blotting - Positive Correlation with Coronary Artery Disease: After Cardiac Transplantation , 1993 .
[27] J. Hosenpud,et al. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] W. S. Ring,et al. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. , 1990, Circulation.
[29] N. Arber,et al. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. , 1990, The New England journal of medicine.
[30] H. Cohen,et al. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients. , 1988, Thrombosis research.
[31] D.,et al. Regression Models and Life-Tables , 2022 .